Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
Clinical trial NCT01502605 · TERMINATED
Trial details
- NCT number
- NCT01502605
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2015-05-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.